Trial · NCT03373383
Participant flow65
How many started, completed or left each group, period by period.
1 to 20 of 65
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period: Wk0-16 | STARTED | Placebo | 83 | |
| Treatment Period: Wk0-16 | STARTED | Padsevonil 50mg BID | 81 | |
| Treatment Period: Wk0-16 | STARTED | Padsevonil 100mg BID | 83 | |
| Treatment Period: Wk0-16 | STARTED | Padsevonil 200mg BID | 82 | |
| Treatment Period: Wk0-16 | STARTED | Padsevonil 400mg BID | 82 | |
| Treatment Period: Wk0-16 | Completed Titration and Stabilization | Placebo | 78 | |
| Treatment Period: Wk0-16 | Completed Titration and Stabilization | Padsevonil 50mg BID | 72 | |
| Treatment Period: Wk0-16 | Completed Titration and Stabilization | Padsevonil 100mg BID | 71 | |
| Treatment Period: Wk0-16 | Completed Titration and Stabilization | Padsevonil 200mg BID | 68 | |
| Treatment Period: Wk0-16 | Completed Titration and Stabilization | Padsevonil 400mg BID | 65 | |
| Treatment Period: Wk0-16 | Completed Maintenance Period | Placebo | 70 | |
| Treatment Period: Wk0-16 | Completed Maintenance Period | Padsevonil 50mg BID | 66 | |
| Treatment Period: Wk0-16 | Completed Maintenance Period | Padsevonil 100mg BID | 68 | |
| Treatment Period: Wk0-16 | Completed Maintenance Period | Padsevonil 200mg BID | 61 | |
| Treatment Period: Wk0-16 | Completed Maintenance Period | Padsevonil 400mg BID | 58 | |
| Treatment Period: Wk0-16 | Had Taper and Safety Follow-up | Placebo | 6 | |
| Treatment Period: Wk0-16 | Had Taper and Safety Follow-up | Padsevonil 50mg BID | 11 | |
| Treatment Period: Wk0-16 | Had Taper and Safety Follow-up | Padsevonil 100mg BID | 8 | |
| Treatment Period: Wk0-16 | Had Taper and Safety Follow-up | Padsevonil 200mg BID | 18 | |
| Treatment Period: Wk0-16 | Had Taper and Safety Follow-up | Padsevonil 400mg BID | 21 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03373383/flow